Application no. and date | 01903352.1 (espacenet) (Federated) (European Patent Register), 20010126 | Patent/reg. no. and date | DK/EP 1265928, 20100721 | Publication date | 20021218 | Priority no. and date | US 178426 P, 20000127 | EP pub. no. and date |
EP 1265928 20021218 | Effective date | | Applicant/owner | MedImmune, LLC, One MedImmune Way
Gaithersburg, MD 20878, US | Applicant ref. no. | 10135-2 | Inventor | KOENIG, Scott, 10901 Ralston Road
Rockville, MD 20852, US, YOUNG, James, F., 14809 Mockingbird Drive
Darnestown, MD 20874, US, HUSE, William, D., 1993 Zapo Street
Del Mar, CA 92014, US, WU, Herren, 7550 Kirby Drive
Houston, TX 77030, US, WATKINS, Jeffry, D., 455 Jolina Way
Encinitis, CA 92024, US, JOHNSON, Leslie, S., 20147 Laurel Hill Way
Germantown, MD 20874, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 39/42 (2006.01) , A61P 31/12 (2006.01) , A61P 31/14 (2006.01) , C07K 16/10 (2006.01) | Title | RSV-neutraliserende antistoffer med ultra høj affinitet | Int. application no. | US2001002618 | Int. publication no. | WO2001055217 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|